Structural pharmacogenomic approach to the evaluation of drug resistant mutations in HIV-1 protease

Journal of Clinical Ligand Assay

Volumn 24, Issue 2, 2001, Pages 140-144

  Shenderovich, M ^a   Ramnarayan, K ^a   Kagan, R ^a   Hess, P ^a  

^a Structural Bioinformatics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPRENAVIR; INDINAVIR; PROTEINASE INHIBITOR; RITONAVIR; SAQUINAVIR;

BINDING AFFINITY; COMPLEX FORMATION; CONFERENCE PAPER; COVALENT BOND; CRYSTAL STRUCTURE; DRUG RECEPTOR BINDING; ENZYME INHIBITION; GENE MUTATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLECULAR MODEL; MUTAGENESIS; PHARMACOGENOMICS; SCREENING;

EID: 0034763953     PISSN: 10811672     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (21)

1. Active human immunodeficiency virus protease is required for viral infectivity
2. Targeting the HIV-protease in AIDS therapy: A current clinical perspective
3. Resistance to human immunodeficiency virus type 1 protease inhibitors
4. Mitsuya H, Erickson JW, Kinetic characterization and cross-resistance patterns of HIV-1 protease mutants selected under drug pressure
5. Resistance and cross-resistance with saquinavirother HIV protease inhibitors: Theory and practice
6. Molecular mechanics analysis of drug-resistant mutants of HIV protease
7. Energy parameters in polypeptides. 10. Improved geometrical parameters and nonbonded interactions for use in the ECEPP/3 algorithm, with application to proline-containing peptides
8. Energy strain in three-dimensional protein structures
9. Protein structure prediction by global energy optimization
10. Biased probability Monte Carlo conformational searches and electrostatic calculations for peptides proteins
11. ICM-a new method for protein modeling and design: Applications to docking and structure prediction from the disordered native conformation
12. ICM Version 2.7
13. How and why phosphotyrosine-containing peptides bind to the SH2 and PTB domains
14. Prediction of the binding energy for small molecules, peptides and proteins
15. Resistance to HIV protease inhibitors: A comparison of enzyme inhibition and antiviral potency
16. Human immunodeficiency virus Mutations in the viral protease that confer resistance to saquinavir increase the dissociation rate constant of the protease-saquinavir complex
17. Selection and analysis of human immunodeficiency virus type 1 variants with increased resistance to ABT-538, a novel protese inhibitor
18. Kinetic characterization of human immunodeficiency virus type-1 protease-resistant variants
19. Exploration of the conformational space of oxytocin and arginine-vassopressin using the electrostatically driven Monte Carlo and molecular dynamics methods
20. Mutations in retroviral genes associated with drug resistance: 2000-2001 Update
21. Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor